All Type of News
Bioequivalence testing to be made compulsory for new combination drugs
Pharmaceutical firms will be obliged to conduct bioequivalence testing for new combination medicines from July this year, according to the Korea Food and Drug Administration.
Under the newly revised regulation, a t...
Food manufacture ordered to describe “food irradiation” label
Any irradiated foods, such as potato and onion, must go through a strict safety assessment from this year and, if approved, must be labelled as having been treated by radiation, according to the Korea.
To date, a t...
KPMA reshuffle aims to boost public relation campaign
The Korea Pharmaceutical Manufacturers Association (KPMA) said it has conducted an organizational and personnel reshuffle, aimed at strengthening its public relation activities for drug price.
Under the reshuffle, ...
Chong Kun Dang names new executives in shake-up
Chong Kun Dang Pharmaceutical Co. said on January 1 that it has promoted Kim Young-eun (photo), a head of management board, as its vice chairman in a management reshuffle which involved several executives.
The lead...
Seeking creation change, Choong-wae reshuffle executives
Most Korean pharmaceutical firms have completed the annual major reshuffles of their top executives, which caught extra attention this year because of the unexpected environments at home and abroad.
Choong-wae Hold...
Concerns growing over sales pattern of foreign invested wholesaling firm
There are mounting concerns among wholesalers in Pusan that Kyungdong Sa, a foreign-invested wholesaling firm, is impending fair competition.
At present, Kyungdong Sa is striving to secure its pharmacy outlets by p...
KFDA to encourage reporting of drug related adverse events
The Korea Food and Drug Administration is considering encouraging pharmaceutical firms to report adverse events associated with medicines to ensure better public health.
To this end, the drug agency has established...
CTCBIO to file appeal against Korean Intellectual Property Tribunal ruling
A local biopharmaceutical company challenged December 28 decision by the Korean Intellectual Property Tribunal to disapprove of its anti-obesity related patent right.
CTCBIO said it wouldn't accept the decision.
...
Wooridul Life Sciences listed in Korea Exchange
Wooridul Life Sciences said on December 30 the company successfully listed its shares on the main stock bourse after the company filed for initial public offerings (IPO) last month.
Wooridul Life Sciences was spli...
Korea Prime targets W60 bil. in sales this year
Korea Prime Pharm aims to achieve 60 billion won in this year’s sales with the intention of emerging as one of the R&D oriented companies in Korea, a company executive said.
“We will reach 60 billion won in sales t...
